These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 24228478)
21. [Definition of treatment-refractory obsessive-compulsive disorder based on cognitive behavioral therapy]. Shimizu E Seishin Shinkeigaku Zasshi; 2013; 115(9):975-80. PubMed ID: 24228475 [TBL] [Abstract][Full Text] [Related]
22. Obsessive-compulsive disorder: a critical review of therapeutic perspectives. Schruers K; Koning K; Luermans J; Haack MJ; Griez E Acta Psychiatr Scand; 2005 Apr; 111(4):261-71. PubMed ID: 15740462 [TBL] [Abstract][Full Text] [Related]
23. Antipsychotic treatment in obsessive-compulsive disorder: a literature review. Keuneman RJ; Pokos V; Weerasundera R; Castle DJ Aust N Z J Psychiatry; 2005 May; 39(5):336-43. PubMed ID: 15860020 [TBL] [Abstract][Full Text] [Related]
24. Use of atypical antipsychotics in refractory depression and anxiety. Nemeroff CB J Clin Psychiatry; 2005; 66 Suppl 8():13-21. PubMed ID: 16336032 [TBL] [Abstract][Full Text] [Related]
25. Treating obsessive-compulsive disorder. Options include medication, psychotherapy, surgery, and deep brain stimulation. Harv Ment Health Lett; 2009 Mar; 25(9):4-5. PubMed ID: 19368037 [No Abstract] [Full Text] [Related]
26. [Resistance and refractoriness in obsessive-compulsive disorder]. Ferrão YA; Diniz JB; Lopes AC; Shavitt RG; Greenberg B; Miguel E Braz J Psychiatry; 2007 Oct; 29 Suppl 2():S66-76. PubMed ID: 18172943 [TBL] [Abstract][Full Text] [Related]
27. [Is there a specific pharmacological treatment for anxiety disorders? Summary of a controversy]. Todorov C Sante Ment Que; 2004; 29(1):127-36. PubMed ID: 15470568 [TBL] [Abstract][Full Text] [Related]
29. The use of antipsychotics in obsessive compulsive disorder. Conti D; Girone N; Boscacci M; Casati L; Cassina N; Cerolini L; Giacovelli L; Viganò C; Conde MM; Cremaschi L; Dell'Osso BM Hum Psychopharmacol; 2024 May; 39(3):e2893. PubMed ID: 38340275 [TBL] [Abstract][Full Text] [Related]
30. Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression. Otsuka T; Togo T; Sugiyama N; Uehara K; Yoshimi A; Karashima A; Shioya H; Hirayasu Y Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):564-6. PubMed ID: 17166643 [TBL] [Abstract][Full Text] [Related]
31. [Clinical features, treatments and outcome of obsessive-compulsive disorder (OCD) focusing on the assessment and characteristics of patients with treatment-refractory OCD]. Matsunaga H Seishin Shinkeigaku Zasshi; 2013; 115(9):967-74. PubMed ID: 24228474 [TBL] [Abstract][Full Text] [Related]
33. A review of the treatment for refractory obsessive-compulsive disorder: from medicine to deep brain stimulation. Husted DS; Shapira NA CNS Spectr; 2004 Nov; 9(11):833-47. PubMed ID: 15520607 [TBL] [Abstract][Full Text] [Related]
34. Cognitive-coping therapy for obsessive-compulsive disorder: a randomized controlled trial. Ma JD; Wang CH; Li HF; Zhang XL; Zhang YL; Hou YH; Liu XH; Hu XZ J Psychiatr Res; 2013 Nov; 47(11):1785-90. PubMed ID: 23988179 [TBL] [Abstract][Full Text] [Related]
35. Treating OCD: what to do when first-line therapies fail. Castle D; Bosanac P; Rossell S Australas Psychiatry; 2015 Aug; 23(4):350-3. PubMed ID: 26104775 [TBL] [Abstract][Full Text] [Related]
37. Deep brain stimulation versus anterior capsulotomy for obsessive-compulsive disorder: a review of the literature. Pepper J; Hariz M; Zrinzo L J Neurosurg; 2015 May; 122(5):1028-37. PubMed ID: 25635480 [TBL] [Abstract][Full Text] [Related]
38. An overview of the pharmacological options for pediatric obsessive-compulsive disorder. Marazziti D; Pozza A Expert Opin Pharmacother; 2022 Nov; 23(16):1793-1800. PubMed ID: 36310087 [TBL] [Abstract][Full Text] [Related]
39. Pharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approach. Uguz F Braz J Psychiatry; 2015; 37(4):334-42. PubMed ID: 26692431 [TBL] [Abstract][Full Text] [Related]